Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kiovig versus Gammagard in chronic inflammatory demyelinating polyradiculoneuropathy
NL-OMON24420Active, not recruiting
- Sponsor
- Pieter A. van Doorn
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic inflammatory demyelinating polyneuropathy (CIDP) comparing Kiovig comparison arm with Gammagard comparison arm (2 arms). Primary endpoints: Overall Disability Sum Score change, Grip strength by vigorimeter and 1 more. Started Jul 2007; status: active, not recruiting.
02
Drugs
kiovigpolyvalent human immunoglobulin
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on NL-OMON24420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24420.